4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-065223
SVP & Chief Accounting Officer sold 6,741 shares at $13.16 ($88,712)
- SVP & Chief Accounting Officer acquired 14,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Thomsen Jillian B. · SVP & Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-15 | Grant or award : show line 1 in the form | +14,900 | 152,722 | D | ||
| 2021-11-16 | Sale : show line 2 in the form | −6,741 | $13.16 | $88,712 | 145,981 | D |
| Open-market sales · 6,741 sh · avg $13.16 · $88,712 | ||||||
Loading xslF345X03/doc4.xml…